Marijuana Moment: Congressional Republicans target cannabis expungements law in DC (Newsletter: September 9, 2025)

September 9

Congresswoman: Marijuana reform at “standstill” under Trump; Poll on legalization as “good” or “bad” for society; Study: Cannabis reduces alcohol use

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Get our daily newsletter.

Email address:

Leave this field empty if you're human:

Your support makes Marijuana Moment possible…

Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going.

Join us at https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

The House Oversight and Government Reform Committee will vote on a bill to overturn a local Washington, D.C. marijuana expungements law on Wednesday, with Chairman James Comer (R-KY) saying, “President Trump and House Republicans are committed to restoring law and order in our nation’s capital city.”

Congressional Cannabis Caucus Co-chair Rep. Dina Titus (D-NV) said federal marijuana reform is at a “standstill” and a “crossroads” as President Donald Trump takes his time deciding on a rescheduling proposal.

“He promised a lot of things during the campaign that haven’t happened, but that’s one of them, and so we aren’t really sure what his position is going to be.”

Mike Tyson spoke about the need for federal marijuana rescheduling on a podcast hosted by Katie Miller, the wife of White House Deputy Chief of Staff for Policy Stephen Miller—saying he’s expecting “good news” on the issue soon.

A new poll shows that more American adults think marijuana legalization has been a “good thing for society” than believe it has been a “bad thing”—but the largest share of respondents feel neutral about the policy’s impacts.

New federally funded research found that marijuana use “was associated with a reduction in alcohol intake”—with the researchers calling it the “first study to test effects of legal-market cannabis on alcohol intake.”

“Those who drank less after cannabis reported greater decreases in alcohol craving.”

/ FEDERAL

The Drug Enforcement Administration posted another profile of one of its special agents.

Sen. Roger Marshall (R-KS) said Rep. Ilhan Omar’s (D-MN) husband started a venture capital company that specializes in part in cannabis.

/ STATES

Pennsylvania regulators published an updated list of pesticides that can be used by medical cannabis growers and processors.

The North Carolina Supreme Court will hear arguments in cases on whether the smell of cannabis provides probable cause for a police search on Tuesday.

A Michigan judge dismissed marijuana possession charges against former school officials, ruling that the state’s legalization law takes precedence over an older statute that made it a crime to have cannabis within 1,000 feet of a school.

Connecticut regulators are moving forward with proposed hemp product rules.

Oklahoma regulators sent guidance about a new requirement for physicians to undergo specific education before issuing medical cannabis recommendations.

California regulators sent updates on cannabis pre-rolls, tinctures, labeling and other issues.

Washington State regulators launched enhancements to their cannabis reporting system.

Missouri regulators published the latest episode of their marijuana podcast.

Georgia regulators will consider renewing medical cannabis production licenses on Wednesday.

—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—

/ INTERNATIONAL

A Canadian government report found that roadside cannabis impairment tests are unreliable.

Moroccan officials approved licenses for 67 cannabis-based products.

/ SCIENCE & HEALTH

A study found “compelling evidence for the therapeutic potential of CBD oil in mitigating motor and cognitive deficits and neuropathological changes associated with” Alzheimer’s disease.

A study found that “psilocybin-assisted therapy yielded large effect sizes for reduction in depressive symptoms in both short-term and long-term follow-up” but that “meta-regression revealed no statistically significant association between the amount of therapy hours and treatment outcomes.”

/ ADVOCACY, OPINION & ANALYSIS

U.S. Hemp Roundtable members met with members of Congress and Trump administration officials.

/ BUSINESS

Charlotte’s Web Holdings, Inc. is establishing a scientific advisory board.

/ CULTURE

Basketball player Julius Randle discussed his decision to quit using marijuana.